EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
3.1.1.2 | Ca2+ | 2 mM used in assay conditions | Homo sapiens | |
3.1.1.25 | Ca2+ | 2 mM used in assay conditions | Homo sapiens | |
3.1.8.1 | Ca2+ | 2 mM used in assay conditions | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.1.1.2 | Homo sapiens | - |
- |
- |
3.1.1.25 | Homo sapiens | - |
- |
- |
3.1.8.1 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.1.1.2 | blood serum | - |
Homo sapiens | - |
3.1.1.25 | blood serum | - |
Homo sapiens | - |
3.1.8.1 | blood serum | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.1.1.2 | phenyl acetate + H2O | - |
Homo sapiens | phenol + acetate | - |
? | |
3.1.1.25 | dihydrocoumarin + H2O | - |
Homo sapiens | 3-(2-hydroxyphenyl)propanoic acid | - |
? | |
3.1.8.1 | paraoxon + H2O | - |
Homo sapiens | 4-nitrophenol + diethyl phosphate | - |
? |
EC Number | Organism | Comment | Expression |
---|---|---|---|
3.1.1.2 | Homo sapiens | enzyme activities in fluorosis patients are considerably decreased up to 56.45% (mild), 61.5% (moderate) and 50% (severe) as compared to control group | down |
3.1.1.25 | Homo sapiens | enzyme activities in fluorosis patients are considerably decreased up to 56.45% (mild), 61.5% (moderate) and 50% (severe) as compared to control group | down |
3.1.8.1 | Homo sapiens | enzyme activities in fluorosis patients are considerably decreased up to 56.45% (mild), 61.5% (moderate) and 50% (severe) as compared to control group | down |